Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

BioNovoGene Completes $15 Million Round for Metabolomics Services

publication date: May 17, 2021

Suzhou BioNovoGene completed a $15 million Series A funding to support its metabolomics services including mass spectrometry test kits. Founded in 2013, the company has established a complete metabolomics testing and analysis platform. Its cloud data analysis system, BioDeep™ has independent intellectual property rights. The company will use the funds to expand its technology platform and develop additional clinical mass spectrometry test kits/products for metabolomics. The round was led by YuanBio Venture Capital. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital